{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:27:38Z","timestamp":1759177658523,"version":"3.44.0"},"reference-count":15,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1975,3]]},"abstract":"<jats:p>The kinetics of hepatic indocyanine green (ICG) uptake have been analysed in 14 patients with chronic active liver disease. The removal of incremental, submaximal ICG doses were compatible with Michaelis-Menten kinetics in approximately 80% of studies in patients allowing the calculation of the maximal rate of removal (Rmax) and the Michaelis constant (Km). Neither of these variables correlated with other laboratory indices of liver function. Although determinations of Rmax before and after a two-weeks trial of azathioprine therapy were not significantly different, in two patients Rmax was markedly reduced by treatment. It is concluded that azathioprine over the short term does not improve the liver's reserve for ICG removal; in fact, in isolated cases this drug may be detrimental.<\/jats:p>","DOI":"10.1136\/gut.16.3.214","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"214-219","source":"Crossref","is-referenced-by-count":7,"title":["Influence of azathioprine on hepatic reserve in chronic active liver disease."],"prefix":"10.1136","volume":"16","author":[{"given":"L","family":"Rikkers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Sherlock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1975,3,1]]},"reference":[{"key":"ref_1","first-page":"159","article-title":"Controlled prospective trial of corticosteroid therapy in active chronic hepatitis","volume":"40","author":"Cook, G.C.; Mulligan, R.; Sherlock, S.","year":"1971","unstructured":"Cook, G. C., Mulligan, R., and Sherlock, S. (1971). Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Quant. J. Med., 40, 159-185.","journal-title":"Quant. J. Med"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/gut.9.3.270","article-title":"Effect of corticosteroid therapy on bromsulphthalein excretion in active chronic hepatitis","volume":"9","author":"Cook, G.C.; Velasco, M.; Sherlock, S.","year":"1968","unstructured":"Cook, G. C., Velasco, M., and Sherlock, S. (1968). Effect of corticosteroid therapy on bromsulphthalein excretion in active chronic hepatitis. Gut, 9, 270-283.","journal-title":"Gut"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/bmj.1.5897.49","article-title":"Treatment of psoriasis with azathioprine","volume":"1","author":"Du Vivier, A.; Munro, D.D.; Verbov, J.","year":"1974","unstructured":"Du Vivier, A., Munro, D. D., and Verbov, J. (1974). Treatment of psoriasis with azathioprine. Brit. med. J., 1, 49-51.","journal-title":"Brit. med. J"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1172\/JCI104387","article-title":"The plasma removal of indocyanine green and sulphobromopthalein: effect of dosage and blocking agents","volume":"40","author":"Hunton, D.B.; Bollman, J.L.; Hoffman, H.N.","year":"1961","unstructured":"Hunton, D. B., Bollman, J. L., and Hoffman, H. N. (1961). The plasma removal of indocyanine green and sulphobromopthalein: effect of dosage and blocking agents. J. clin. Invest., 40, 1648-1655.","journal-title":"J. clin. Invest"},{"key":"ref_5","first-page":"236","article-title":"Indocyanine green clearance as a test for hepatic function: evaluation by dichromatic ear densitometry","author":"Leevy, C.M.Smith; F., Longueville; J., Paumgartner; G.; Howard, M.M.","year":"1967","unstructured":"Leevy, C. M. Smith, F., Longueville, J., Paumgartner, G., and Howard, M. M. (1967). Indocyanine green clearance as a test for hepatic function: evaluation by dichromatic ear densitometry. J. Amer. med. Ass., 200, 236-240.","journal-title":"J. Amer. med. Ass"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ja01318a036","article-title":"The determination of enzyme dissociation constants","volume":"56","author":"Lineweaver, H.; Burk, D.","year":"1934","unstructured":"Lineweaver, H., and Burk, D. (1934). The determination of enzyme dissociation constants. J. Amer. chem. Soc., 56, 658-666.","journal-title":"J. Amer. chem. Soc"},{"key":"ref_7","first-page":"592598","article-title":"Estimation of the functional reserve of human liver","volume":"180","author":"Moody, F.G.; Rikkers, L.F.; Aldrete, J.S.","year":"1974","unstructured":"Moody, F. G., Rikkers, L. F., and Aldrete, J. S. (1974). Estimation of the functional reserve of human liver. Ann Surg., 180, 592598.","journal-title":"Ann Surg"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.1970.tb37009.x","article-title":"Kinetics of indocyanine green removal from the blood","volume":"170","author":"Paumgartner, G.; Probst, P.; Kraines, R.; Leevy, C.M.","year":"1970","unstructured":"Paumgartner, G., Probst, P., Kraines, R., and Leevy, C. M. (1970). Kinetics of indocyanine green removal from the blood. Ann. N.Y. Acad. Sci., 170, 134-147.","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0016-5085(19)32796-9","article-title":"Estimation of functional hepatic mass in resected and regenerating rat liver","volume":"67","author":"Rikkers, L.F.; Moody, F.G.","year":"1974","unstructured":"Rikkers, L. F., and Moody, F. G. (1974a). Estimation of functional hepatic mass in resected and regenerating rat liver. Gastroenterology, 67, 691-699.","journal-title":"Gastroenterology"},{"key":"ref_10","first-page":"421","article-title":"Estimation of functional reserve of normal and regenerating dog livers","volume":"75","author":"Rikkers, L.F.; Moody, F.G.","year":"1974","unstructured":"Rikkers, L. F., and Moody, F. G. (1974b). Estimation of functional reserve of normal and regenerating dog livers. Surgery, 75, 421-429.","journal-title":"Surgery"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical biochemical and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis","volume":"63","author":"Soloway, R.D.; Summerskill, W.H.J.; Baggenstoss, A.H.; Geall, M.G.; Gitnick, G.L.; Elveback, L.R.; Schoenfeld, L.J.","year":"1972","unstructured":"Soloway, R. D., Summerskill, W. H. J., Baggenstoss, A. H., Geall, M. G., Gitnick, G. L., Elveback, L. R., and Schoenfeld, L. J. (1972). Clinical biochemical and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology, 63, 820-833.","journal-title":"Gastroenterology"},{"issue":"92","key":"ref_12","first-page":"118","article-title":"Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand","volume":"18","author":"Tygstrup, N.","year":"1966","unstructured":"Tygstrup, N. (1966). Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand. J. clin. Lab. Invest., 18, Suppl. 92, 118-125.","journal-title":"J. clin. Lab. Invest"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1172\/JCI104128","article-title":"Biliary transport and hepatic storage of sulfobromopthalein sodium in the unanesthetized dog, in normal man, and in patients with hepatic disease","volume":"39","author":"Wheeler, H.O.; Meltzer, J.I.; Bradley, S.E.","year":"1960","unstructured":"Wheeler, H. O., Meltzer, J. I., and Bradley, S. E. (1960). Biliary transport and hepatic storage of sulfobromopthalein sodium in the unanesthetized dog, in normal man, and in patients with hepatic disease. J. clin. Invest., 39, 1131-1144.","journal-title":"J. clin. Invest"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/gut.13.11.907","article-title":"Immunosuppressive activity in patients with active chronic hepatitis and primary biliary cirrhosis treated with azathioprine","volume":"13","author":"Whelan, G.; Sherlock, S.","year":"1972","unstructured":"Whelan, G., and Sherlock, S. (1972). Immunosuppressive activity in patients with active chronic hepatitis and primary biliary cirrhosis treated with azathioprine. Gut, 13, 907-914.","journal-title":"Gut"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/jama.1972.03210060044010","article-title":"Irreversible liver damage after azathioprine","volume":"222","author":"Zarday, Z.; Veith, F.J.; Gliedman, M.L.; Soberman, R.","year":"1972","unstructured":"Zarday, Z., Veith, F. J., Gliedman, M. L., and Soberman, R. (1972). Irreversible liver damage after azathioprine. J. Amer. med. Ass., 222, 690-691.","journal-title":"J. Amer. med. Ass"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.16.3.214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T21:06:27Z","timestamp":1757279187000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.16.3.214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1975,3]]},"references-count":15,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1975,3,1]]},"published-print":{"date-parts":[[1975,3]]}},"alternative-id":["10.1136\/gut.16.3.214"],"URL":"https:\/\/doi.org\/10.1136\/gut.16.3.214","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"type":"print","value":"0017-5749"},{"type":"electronic","value":"1468-3288"}],"subject":[],"published":{"date-parts":[[1975,3]]}}}